Chemotherapy-free innovations in locally advanced head and neck cancer: a comprehensive review.

Front Oncol · 2025 · PMC12052741 · PMID 40330829

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

While pembrolizumab combined with CCRT showed a favorable trend towards improved event-free survival (EFS) compared to placebo with CCRT, the difference was not statistically significant.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.